![Benjamin Cappiello](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Benjamin D.
Cappiello has founded Bioceptive, Inc. in 2010 where he holds the title of Director.
Currently, he is a Director at AxoSim, Inc.
Benjamin Cappiello active positions
Companies | Position | Start |
---|---|---|
Bioceptive, Inc.
![]() Bioceptive, Inc. Medical SpecialtiesHealth Technology Bioceptive, Inc. develops medical devices for gynecological procedures. Its products includes, intrauterine device (IUD) inserter that vastly simplifies the insertion procedure, while reducing the complications inherent with current insertion techniques. The company was founded by Shuchi Khurana and Benjamin D. Cappiello in September 2010 and is ehadquartered in New Orleans, LA. | Founder | 31/08/2010 |
AxoSim, Inc.
![]() AxoSim, Inc. Packaged SoftwareTechnology Services Axosim, Inc. operates as a biotechnology company that develops nerve-on-a-chip platform. The company was founded by Lowry Curley and Michael Moore and is headquartered in New Orleans, LA. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Bioceptive, Inc.
![]() Bioceptive, Inc. Medical SpecialtiesHealth Technology Bioceptive, Inc. develops medical devices for gynecological procedures. Its products includes, intrauterine device (IUD) inserter that vastly simplifies the insertion procedure, while reducing the complications inherent with current insertion techniques. The company was founded by Shuchi Khurana and Benjamin D. Cappiello in September 2010 and is ehadquartered in New Orleans, LA. | Health Technology |
AxoSim, Inc.
![]() AxoSim, Inc. Packaged SoftwareTechnology Services Axosim, Inc. operates as a biotechnology company that develops nerve-on-a-chip platform. The company was founded by Lowry Curley and Michael Moore and is headquartered in New Orleans, LA. | Technology Services |
- Stock Market
- Insiders
- Benjamin Cappiello